ÂÜÀòÂÒÂ×

Dr. Drakas has observer status on the Evrys Bio Board of Directors. He is Vice President of ShangPharma Innovation. He previously served as the senior director of Business Development at ChemPartner Inc., a leading research organization providing services for the biopharmaceutical industry. Earlier in his career, Dr. Drakas served as a senior analyst and senior research biochemist at Merck. He received a B.S. degree in biology from the University of Scranton, an M.S. in biochemistry from Drexel University, and a Ph.D. in molecular pharmacology from Thomas Jefferson University.